Unicycive Therapeutics, Inc.UNCYNASDAQ

Revenue (LTM)

-100.0% YoY

Net Income (LTM)

$-37M

-20.2% YoY

Free Cash Flow

$-29M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.0B)

Unprofitable

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Revenue	0	0	1	1↓29.0%	0
Gross Profit	0	0	1	1↓29.0%	0
Operating Income	-2	-9↓344.4%	-18↓101.1%	-21↓15.1%	-32↓54.6%
Net Income	-3	-10↓299.4%	-18↓80.3%	-31↓69.1%	-37↓20.2%
EBITDA	0	-9	-18↓90.8%	-30↓68.7%	-36↓20.1%
EPS Diluted	-0.16	-8.60↓5275.0%	-1.20↑86.0%	-1.28↓6.7%	-5.60↓337.5%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Cash & Equivalents	0	17	0↓97.3%	10↑2032.1%	26↑169.5%
Total Current Assets	0	18↑8925.0%	3↓85.6%	13↑406.8%	31↑131.0%
Total Assets	0	19↑9088.2%	3↓85.0%	14↑403.6%	32↑123.2%
Total Current Liabilities	3	2↓26.8%	3↑56.0%	18↑433.9%	24↑37.6%
Total Liabilities	3	2↓21.4%	3↑45.3%	18↑448.1%	24↑34.6%
Total Equity	-3	16↑717.1%	-0↓102.8%	-4↓717.4%	7↑295.1%
Total Debt	3	0↓86.7%	0↓40.0%	1↑303.5%	1↓4.7%
Net Debt	3	-16↓746.1%	-0↑98.4%	-9↓3400.0%	-25↓185.4%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Operating Cash Flow	-1	-6↓295.3%	-16↓171.4%	-18↓16.8%	-29↓56.3%
Capital Expenditure	0	-0	-0↑93.1%	-0↓500.0%	-0↓500.0%
Free Cash Flow	-1	-6↓297.3%	-16↓170.1%	-18↓16.9%	-29↓56.6%
Stock-Based Comp	0	1↑316.4%	1↑8.4%	2↑68.8%	2↑33.0%
Net Change in Cash	-0	17↑110626.7%	-16↓197.3%	9↑157.3%	16↑77.8%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance